Researchers discover biomarker for tracking depression recovery
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Source: National Institutes of Health (NIH) News Releases - September 20, 2023 Category: American Health Source Type: news

Uganda: MSF Ends Support to HIV Programme in Arua After More Than 20 Years
[MSF] For over 20 years, Médecins Sans Frontières (MSF) has supported the Ministry of Health with treatment for people living with HIV/AIDS in the West Nile region of Uganda and more specifically, in the Arua district.
Source: AllAfrica News: Health and Medicine - September 20, 2023 Category: African Health Tags: Aid and Assistance HIV-Aids and STDs East Africa External Relations Health and Medicine International Organizations and Africa NGOs and Civil Society Uganda Source Type: news

The Man Who Thinks He Can Live Forever
In a neat little neighborhood in Venice, Calif., there’s a block of squat, similar homes, filled with mortals spending their finite days on the planet eating pizza with friends, blowing out candles on birthday cakes, and binging late-night television. Halfway down the street, there’s a cavernous black modern box. This is where Bryan Johnson is working on what he calls “the most significant revolution in the history of Homo sapiens.”  [time-brightcove not-tgx=”true”] Johnson, 46, is a centimillionaire tech entrepreneur who has spent most of the last three years in pursuit of a si...
Source: TIME: Health - September 20, 2023 Category: Consumer Health News Authors: Charlotte Alter Tags: Uncategorized feature Source Type: news

Dynamic Risk Assessment for HCC in Patients With Chronic HCV Dynamic Risk Assessment for HCC in Patients With Chronic HCV
The authors developed a model for identifying hepatocellular carcinoma risk factors in individuals with chronic HCV, across antiviral treatment status and interactions with cirrhosis.Journal of Viral Hepatitis
Source: Medscape Today Headlines - September 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA declines to approve first needle-free option to EpiPen
Federal regulators have declined to approve the first needle-free epinephrine treatment for people who suffer from severe allergic reactions, requesting its developer, ARS Pharmaceuticals, to conduct further testing.
Source: Health News - UPI.com - September 20, 2023 Category: Consumer Health News Source Type: news

One of the world's top hormone experts is suspended for gaining illicit access to confidential medical records of more than 100 patients being held by a competitor
Dr Marion Gluck, 73, known globally for her pioneering treatment of hormonal imbalances, asked another doctor for the sensitive log-in information 'as a favour'.
Source: the Mail online | Health - September 20, 2023 Category: Consumer Health News Source Type: news

How Much Do Patients Need to Know About a Potentially Risky Treatment?
An unapproved product made from umbilical cord blood was used at a prominent New York hospital. After an F.D.A. warning came an internal complaint: Patients should have been told.
Source: NYT Health - September 20, 2023 Category: Consumer Health News Authors: Ellen Gabler, Steve Eder and Allie Pitchon Tags: Hospitals Blood Biotechnology and Bioengineering Ethics and Official Misconduct Burst Biologics New York-Presbyterian Hospital Food and Drug Administration Surgery and Surgeons Regulation and Deregulation of Industry Medicine and Health Source Type: news

Four in five people with hypertension aren ’t adequately treated
Just one in five people with hypertension have controlled it, the World Health Organization said. Eighty per cent of people with hypertension don’t receive adequate treatment, according to the World Health Organization (WHO)'s first report on the topic. Though the condition is common with one in…#hypertension #tomfrieden #resolvetosavelives #cdc
Source: Reuters: Health - September 20, 2023 Category: Consumer Health News Source Type: news

OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson
CARY, N.C., Sept. 20, 2023 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by GSK as a specialty pharmacy provider for OJJAARATM (momelotinib).
Source: McKesson News - September 20, 2023 Category: Information Technology Source Type: news

Fatal fall-from-height accidents: Statistical treatment using the Human Factors Analysis and Classification System - HFACS - Santiago Oliveira S, de Albuquerque Soares W, Vasconcelos BM.
INTRODUCTION: The civil construction industry (CCI) is one of the most dangerous sectors for occupational accidents. Studies conducted in several countries show that occupational accidents involving falls from height are the main cause of deaths in recent ...
Source: SafetyLit - September 20, 2023 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Epidemiology of work-related traumatic brain injury (wrTBI) and COVID-19 pandemic lockdown consequences: experience in a reference center in Chile - Wimmer Del Solar J, Rojas-L íbano D, Bastías Barra P, Cisternas Vera C, Chávez Martel P, Rozas Vidal JP, Ibáñez Rodríguez P, Fontecilla Villalobos E.
INTRODUCTION: Work-related Traumatic Brain Injury (wrTBI) is a frequent cause of chronic morbidity, mortality, and high treatment costs. Its causes are highly environmentally determined and were affected by COVID-19 pandemic lockdowns. OBJECTIVE: W...
Source: SafetyLit - September 20, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Gender and criminal justice responses to terrorism in the United States - Jackson SM, Ratcliff K, Gruenewald J.
Generally, women receive more lenient treatment by the criminal justice system compared to men. Prior research on how gender shaped prosecutorial decision-making and sentencing outcomes has focused on conventional forms of crime, while less is known about ...
Source: SafetyLit - September 20, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Takeda Announces FDA Acceptance of NDA Resubmission of TAK-721 (budesonide oral suspension) for the Short-Term Treatment of Eosinophilic Esophagitis (EoE)
OSAKA, Japan and CAMBRIDGE, Massachusetts, September 20, 2023– Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) resubmission for TAK-721...
Source: Drugs.com - New Drug Applications - September 20, 2023 Category: Drugs & Pharmacology Source Type: news

Unlicensed New York acupuncturist accused of causing patient ’s lungs to collapse
Create your free profile or log in to save this article Create your free profile or log in to save this article An unlicensed acupuncturist has been criminally charged after a 63-year-old woman's lungs collapsed as she walked home after receiving treatment from him at his Flushing office,…#flushing #queensdistrict #melindakatz #yongdelin #bethnugent #kathleengallo #mandarin #elderfraud
Source: Reuters: Health - September 19, 2023 Category: Consumer Health News Source Type: news

Progressive Pulmonary Fibrosis: Treatment and Support Progressive Pulmonary Fibrosis: Treatment and Support
Numerous unresolved questions surround PPF treatment and support.Medscape Medical News
Source: Medscape Medical News Headlines - September 19, 2023 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20